Dominari Inc. (DOMH)
3.49
-0.09 (-2.51%)
At close: Jan 31, 2025, 3:59 PM
3.42
-2.01%
After-hours Jan 31, 2025, 05:34 PM EST
undefined% (undefined)
| Bid | 3.28 |
| Market Cap | 22.11M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -3.86 |
| PE Ratio (ttm) | -0.9 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 3.42 |
| Volume | 1,308,766 |
| Avg. Volume (20D) | 58,418 |
| Open | 3.76 |
| Previous Close | 3.58 |
| Day's Range | 3.25 - 4.35 |
| 52-Week Range | 0.83 - 4.35 |
| Beta | undefined |
About DOMH
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also d...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 18, 1980
Employees 26
Stock Exchange NASDAQ
Ticker Symbol DOMH
Website https://www.aikidopharma.com